These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33110268)

  • 21. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
    Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
    J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence from 2100 index cases supports genome sequencing as a first-tier genetic test.
    Guo F; Liu R; Pan Y; Collins C; Bean L; Ma Z; Mathur A; Da Silva C; Nallamilli B; Guruju N; Chen-Deutsch X; Yousaf R; Chin E; Balciuniene J; Hegde M
    Genet Med; 2024 Jan; 26(1):100995. PubMed ID: 37838930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
    Soden SE; Saunders CJ; Willig LK; Farrow EG; Smith LD; Petrikin JE; LePichon JB; Miller NA; Thiffault I; Dinwiddie DL; Twist G; Noll A; Heese BA; Zellmer L; Atherton AM; Abdelmoity AT; Safina N; Nyp SS; Zuccarelli B; Larson IA; Modrcin A; Herd S; Creed M; Ye Z; Yuan X; Brodsky RA; Kingsmore SF
    Sci Transl Med; 2014 Dec; 6(265):265ra168. PubMed ID: 25473036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
    Xie X; Wang M; Goh ES; Ungar WJ; Little J; Carroll JC; Okun N; Huang T; Rousseau F; Dougan SD; Tu HA; Higgins C; Holubowich C; Sikich N; Dhalla IA; Ng V
    J Obstet Gynaecol Can; 2020 Jun; 42(6):740-749.e12. PubMed ID: 32008974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome Sequencing for Isolated Congenital Hearing Loss: A Cost-Effectiveness Analysis.
    Downie L; Amor DJ; Halliday J; Lewis S; Martyn M; Goranitis I
    Laryngoscope; 2021 Jul; 131(7):E2371-E2377. PubMed ID: 33382469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal microarrays testing in children with developmental disabilities and congenital anomalies.
    Lay-Son G; Espinoza K; Vial C; Rivera JC; Guzmán ML; Repetto GM
    J Pediatr (Rio J); 2015; 91(2):189-95. PubMed ID: 25458876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High diagnostic potential of short and long read genome sequencing with transcriptome analysis in exome-negative developmental disorders.
    Lecoquierre F; Quenez O; Fourneaux S; Coutant S; Vezain M; Rolain M; Drouot N; Boland A; Olaso R; Meyer V; Deleuze JF; Dabbagh D; Gilles I; Gayet C; Saugier-Veber P; Goldenberg A; Guerrot AM; Nicolas G
    Hum Genet; 2023 Jun; 142(6):773-783. PubMed ID: 37076692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost Effectiveness of Using Array-CGH for Diagnosing Learning Disability.
    Sagoo GS; Mohammed S; Barton G; Norbury G; Ahn JW; Ogilvie CM; Kroese M
    Appl Health Econ Health Policy; 2015 Aug; 13(4):421-32. PubMed ID: 25894741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders.
    Wright CF; McRae JF; Clayton S; Gallone G; Aitken S; FitzGerald TW; Jones P; Prigmore E; Rajan D; Lord J; Sifrim A; Kelsell R; Parker MJ; Barrett JC; Hurles ME; FitzPatrick DR; Firth HV;
    Genet Med; 2018 Oct; 20(10):1216-1223. PubMed ID: 29323667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interest of exome sequencing trio-like strategy based on pooled parental DNA for diagnosis and translational research in rare diseases.
    Tran Mau-Them F; Duffourd Y; Vitobello A; Bruel AL; Denommé-Pichon AS; Nambot S; Delanne J; Moutton S; Sorlin A; ; Couturier V; Bourgeois V; Chevarin M; Poe C; Mosca-Boidron AL; Callier P; Safraou H; Faivre L; Philippe C; Thauvin-Robinet C
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1836. PubMed ID: 34716697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability.
    Malinowski J; Miller DT; Demmer L; Gannon J; Pereira EM; Schroeder MC; Scheuner MT; Tsai AC; Hickey SE; Shen J;
    Genet Med; 2020 Jun; 22(6):986-1004. PubMed ID: 32203227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The performance of genome sequencing as a first-tier test for neurodevelopmental disorders.
    van der Sanden BPGH; Schobers G; Corominas Galbany J; Koolen DA; Sinnema M; van Reeuwijk J; Stumpel CTRM; Kleefstra T; de Vries BBA; Ruiterkamp-Versteeg M; Leijsten N; Kwint M; Derks R; Swinkels H; den Ouden A; Pfundt R; Rinne T; de Leeuw N; Stegmann AP; Stevens SJ; van den Wijngaard A; Brunner HG; Yntema HG; Gilissen C; Nelen MR; Vissers LELM
    Eur J Hum Genet; 2023 Jan; 31(1):81-88. PubMed ID: 36114283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing genome sequencing technologies to improve rare disease diagnostics: a protocol for the evaluation of a pilot project, Genome-wide Sequencing Ontario.
    Hayeems RZ; Marshall CR; Gillespie MK; Szuto A; Chisholm C; Stavropoulos DJ; Venkataramanan V; Tsiplova K; Sawyer S; Price EM; Lau L; Khan R; Lee W; Huang L; Jarinova O; Ungar WJ; Mendoza-Londono R; Somerville MJ; Boycott KM
    CMAJ Open; 2022; 10(2):E460-E465. PubMed ID: 35609929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting cryptic clinically relevant structural variation in exome-sequencing data increases diagnostic yield for developmental disorders.
    Gardner EJ; Sifrim A; Lindsay SJ; Prigmore E; Rajan D; Danecek P; Gallone G; Eberhardt RY; Martin HC; Wright CF; FitzPatrick DR; Firth HV; Hurles ME
    Am J Hum Genet; 2021 Nov; 108(11):2186-2194. PubMed ID: 34626536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Singapore Undiagnosed Disease Program: Genomic Analysis aids Diagnosis and Clinical Management.
    Bhatia NS; Lim JY; Bonnard C; Kuan JL; Brett M; Wei H; Cham B; Chin H; Bosso-Lefevre C; Dharuman P; Escande-Beillard N; Devasia AG; Goh CYJ; Kam S; Liew WK; Liew WK; Lin G; Jain K; Ng AY; Subramanian D; Xie M; Tan YM; Tawari NR; Tiang Z; Ting TW; Tohari S; Tong CK; Lezhava A; Ng SB; Law HY; Venkatesh B; Tomar S; Sethi R; Tan G; Shanmugasundaram A; Goh DL; Lai PS; Lai A; Tan ES; Ng I; Reversades B; Tan EC; Foo R; Jamuar SS;
    Arch Dis Child; 2021 Jan; 106(1):31-37. PubMed ID: 32819910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exome first approach to reduce diagnostic costs and time - retrospective analysis of 111 individuals with rare neurodevelopmental disorders.
    Klau J; Abou Jamra R; Radtke M; Oppermann H; Lemke JR; Beblo S; Popp B
    Eur J Hum Genet; 2022 Jan; 30(1):117-125. PubMed ID: 34690354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical costs of children admitted to the neonatal intensive care unit: The role and possible economic impact of WES in early diagnosis.
    Olde Keizer RACM; Marouane A; Deden AC; van Zelst-Stams WAG; de Boode WP; Keusters WR; Henneman L; van Amstel JKP; Frederix GWJ; Vissers LELM
    Eur J Med Genet; 2022 May; 65(5):104467. PubMed ID: 35240323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies.
    Palmer EE; Sachdev R; Macintosh R; Melo US; Mundlos S; Righetti S; Kandula T; Minoche AE; Puttick C; Gayevskiy V; Hesson L; Idrisoglu S; Shoubridge C; Thai MHN; Davis RL; Drew AP; Sampaio H; Andrews PI; Lawson J; Cardamone M; Mowat D; Colley A; Kummerfeld S; Dinger ME; Cowley MJ; Roscioli T; Bye A; Kirk E
    Neurology; 2021 Mar; 96(13):e1770-e1782. PubMed ID: 33568551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.